Walleye Trading
NVAX icon

Walleye Trading’s Novavax NVAX Stock Holding History

Walleye Trading’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$670K Sell
82,300
-29,200
-26% -$265K ﹤0.01% 2406
2025
Q4 		$749K Sell
111,500
-52,900
-32% -$399K ﹤0.01% 2563
2025
Q3 		$1.43M Sell
164,400
-225,300
-58% -$1.75M ﹤0.01% 2034
2025
Q2 		$2.46M Buy
389,700
+45,300
+13% +$300K ﹤0.01% 1606
2025
Q1 		$2.21M Buy
344,400
+209,100
+155% +$1.73M 0.01% 1585
2024
Q4 		$1.09M Sell
135,300
-2,200
-2% -$21.2K ﹤0.01% 2107
2024
Q3 		$1.74M Buy
137,500
+9,900
+8% +$128K ﹤0.01% 1765
2024
Q2 		$1.62M Sell
127,600
-111,900
-47% -$1.13M ﹤0.01% 1738
2024
Q1 		$1.14M Sell
239,500
-186,300
-44% -$864K ﹤0.01% 2133
2023
Q4 		$2.04M Sell
425,800
-42,900
-9% -$263K ﹤0.01% 1907
2023
Q3 		$3.39M Buy
468,700
+3,800
+0.8% +$30.4K 0.01% 1386
2023
Q2 		$3.45M Buy
464,900
+199,500
+75% +$1.57M 0.01% 1238
2023
Q1 		$1.84M Buy
265,400
+130,600
+97% +$1.2M ﹤0.01% 1749
2022
Q4 		$1.39M Buy
134,800
+63,200
+88% +$1.12M ﹤0.01% 1963
2022
Q3 		$1.3M Buy
71,600
+57,100
+394% +$2.47M ﹤0.01% 2042
2022
Q2 		$746K Sell
14,500
-47,600
-77% -$2.47M ﹤0.01% 2511
2022
Q1 		$4.57M Buy
62,100
+39,900
+180% +$3.56M 0.01% 1059
2021
Q4 		$3.18M Sell
22,200
-30,000
-57% -$5.15M 0.01% 1297
2021
Q3 		$10.8M Buy
52,200
+24,900
+91% +$5.49M 0.04% 512
2021
Q2 		$5.8M Buy
27,300
+25,200
+1,200% +$4.62M 0.02% 713
2021
Q1 		$381K Sell
2,100
-500
-19% -$99.6K ﹤0.01% 2978
2020
Q4 		$290K Sell
2,600
-14,100
-84% -$1.5M ﹤0.01% 3163
2020
Q3 		$1.81M Buy
16,700
+14,600
+695% +$1.78M 0.01% 1199
2020
Q2 		$175K Buy
+2,100
New +$80.3K ﹤0.01% 3166

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's NVAX Position: Q1 2026 in Review

Walleye Trading reduced its Novavax (NVAX) stake by 77% in Q1 2026, selling an estimated $1.2M and leaving 40,148 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #2834.

Walleye Trading first reported a position in NVAX in Q2 2015 and has held it in 16 quarters since. The position peaked at $1.16M in Q4 2025. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Walleye Trading held 40,148 shares of Novavax worth $327K as of Q1 2026.
  • Walleye Trading sold 132,532 Novavax shares in Q1 2026, an estimated $1.2M.
  • Novavax made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2834 holding.
  • Walleye Trading first reported a position in Novavax in Q2 2015 and has held it in 16 quarters since.
  • Walleye Trading's Novavax position peaked at $1.16M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.